A carregar...

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments

Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Mehdi Arbabi-Ghahroudi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
Colecção:International Journal of Molecular Sciences
Assuntos:
VHH
Acesso em linha:https://www.mdpi.com/1422-0067/23/9/5009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!